homocysteine
Small moleculeexperimental
Homocysteine (; symbol Hcy) is a non-proteinogenic α-amino acid. It is a homologue of the amino acid cysteine, differing by an additional methylene bridge (−CH2−). It is biosynthesized from methionine by the removal of its terminal Cε methyl group. In the body, homocysteine can be recycled into methionine or converted into cysteine with the aid of vitamin B6, B9, and B12. — Wikipedia
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2001 (NCT00032435)
Timeline
2000s
- Jan 1, 2001
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHomocysteine ↗
Also known as
- homocysteine
- homocysteine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00032435 | Phase 3 | May 1, 2001 | Abbott, Department of Veteran Affairs, Pamlab |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abbott | For profit | 1 | 0 | 1 | 2001 |
| Department of Veteran Affairs | Government | 1 | 1 | 1 | 2001 |
| Pamlab | For profit | 1 | 0 | 1 | 2001 |
3 organizations
Page 1 / 1